...
首页> 外文期刊>British Journal of Cancer >Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation
【24h】

Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation

机译:酞菁和5-氨基戊酸酯对正常家兔喉的光动力疗法诱导原卟啉IX的光敏作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Photodynamic therapy (PDT) is a promising technique for the treatment of small tumours in organs where it is essential to minimise damage to immediately adjacent normal tissue as PDT damage to many tissues heals by regeneration rather than scarring. As preservation of function is one of the main aims of treating laryngeal tumours, this project studied the effects of PDT on the normal rabbit larynx with two photosensitisers, endogenous protoporphyrin IX (PPIX) induced by the administration of 5-aminolaevulinic acid (ALA) and disulphonated aluminium phthalocyanine (AIS2Pc). The main aims of the study were to examine the distribution of protoporphyrin IX and AIS2Pc by fluorescence microscopy in the different regions of the larnyx and to assess the nature and subsequent healing of PDT damage. Peak levels of PPIX were found 0.5-4 h after administration of ALA (depending on dose) with highest levels in the epithelium of the mucosa. With 100 mg kg-1, PDT necrosis was limited to the mucosa, whereas with 200 mg kg-1 necrosis extended to the muscle. With 1 mg kg-1 AIS2Pc, 1 h after administration, the drug was mainly in the submucosa and muscle, whereas after 24 h, it was predominantly in the mucosa. PDT at 1 h caused deep necrosis whereas at 24 h it was limited to the mucosa. All mucosal necrosis healed by regeneration whereas deeper effects left some fibrosis. No damage to cartilage was seen in any of the animals studied. The results of this study have shown that both photosensitisers are suitable for treating mucosal lesions of the larynx, but that for both it is important to optimise the drug dose and time interval between drug and light to avoid unacceptable changes in normal areas.
机译:光动力疗法(PDT)是一种有前景的技术,可用于治疗器官中的小肿瘤,因为PDT对许多组织的损伤通过再生而不是疤痕愈合,因此必须尽量减少对紧邻的正常组织的损伤。由于保持功能是治疗喉部肿瘤的主要目的之一,因此该项目研究了PDT对两种正常的光敏剂-内源性原卟啉IX(PPIX)的作用,这些光敏剂是通过施用5-氨基乳油酸(ALA)和内源性原卟啉IX(PPIX)引起的。二磺化铝酞菁(AIS2Pc)。该研究的主要目的是通过荧光显微镜检查喉部不同区域中原卟啉IX和AIS2Pc的分布,并评估PDT损伤的性质和随后的治愈。在给予ALA后0.5-4小时(取决于剂量),PPIX的峰值水平在粘膜上皮中最高。 100 mg kg-1时,PDT坏死仅限于粘膜,而200 mg kg-1时,坏死扩展至肌肉。给药1 mg kg-1 AIS2Pc后1小时,该药物主要在粘膜下层和肌肉中,而24小时后,该药物主要在粘膜中。 PDT在1 h引起深层坏死,而在24 h仅局限于粘膜。所有粘膜坏死均通过再生而愈合,而更深的影响则留下了一些纤维化。在所研究的任何动物中均未见软骨损伤。这项研究的结果表明,两种光敏剂均适用于治疗喉黏膜病变,但对于两者而言,优化药物剂量和药物与光之间的时间间隔以避免正常区域发生不可接受的变化非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号